Alkem Laboratories Ltd. (IN:ALKEM)
:ALKEM
Want to see IN:ALKEM full AI Analyst Report?
Total Valuation
Alkem Laboratories Ltd. has a market cap or net worth of ₹642.63B. The enterprise value is ₹657.37B.
Market Cap₹642.63B
Enterprise Value₹657.37B
Share Statistics
Alkem Laboratories Ltd. has 119,565,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding119,565,000
Owned by Insiders―
Owned by Institutions0.02%
Financial Efficiency
Alkem Laboratories Ltd.’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 12.45%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)12.45%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee8.44M
Profits Per Employee1.65M
Employee Count17,432
Asset Turnover0.70
Inventory Turnover1.53
Valuation Ratios
The current PE Ratio of Alkem Laboratories Ltd. is 27.9. Alkem Laboratories Ltd.’s PEG ratio is 4.33.
PE Ratio27.9
PS Ratio4.26
PB Ratio4.54
Price to Fair Value4.54
Price to FCF46.60
Price to Operating Cash Flow76.80
PEG Ratio4.33
Income Statement
In the last 12 months, Alkem Laboratories Ltd. had revenue of 147.12B and earned 23.02B in profits. Earnings per share was 192.51.
Revenue147.12B
Gross Profit96.19B
Operating Income26.23B
Pretax Income28.71B
Net Income23.02B
EBITDA34.14B
Earnings Per Share (EPS)192.51
Cash Flow
In the last 12 months, operating cash flow was 8.37B and capital expenditures -3.96B, giving a free cash flow of 4.40B billion.
Operating Cash Flow8.37B
Free Cash Flow4.40B
Free Cash Flow per Share36.81
Dividends & Yields
Alkem Laboratories Ltd. pays an annual dividend of ₹43, resulting in a dividend yield of 0.8%
Dividend Per Share₹43
Dividend Yield0.8%
Payout Ratio22.78%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change13.93%
50-Day Moving Average5.42K
200-Day Moving Average5.49K
Relative Strength Index (RSI)50.48
Average Volume (3m)9.84K
Important Dates
Alkem Laboratories Ltd. upcoming earnings date is Aug 7, 2026, TBA (Confirmed).
Last Earnings DateMay 28, 2026
Next Earnings DateAug 7, 2026
Ex-Dividend Date―
Financial Position
Alkem Laboratories Ltd. as a current ratio of 2.55, with Debt / Equity ratio of 14.81%
Current Ratio2.55
Quick Ratio1.86
Debt to Market Cap0.03
Net Debt to EBITDA0.53
Interest Coverage Ratio16.32
Taxes
In the past 12 months, Alkem Laboratories Ltd. has paid 5.18B in taxes.
Income Tax5.18B
Effective Tax Rate0.18
Enterprise Valuation
Alkem Laboratories Ltd. EV to EBITDA ratio is 18.90, with an EV/FCF ratio of 47.93.
EV to Sales4.38
EV to EBITDA18.90
EV to Free Cash Flow47.93
EV to Operating Cash Flow32.86
Balance Sheet
Alkem Laboratories Ltd. has ₹51.52B in cash and marketable securities with ₹23.56B in debt, giving a net cash position of ₹27.96B billion.
Cash & Marketable Securities₹51.52B
Total Debt₹23.56B
Net Cash₹27.96B
Net Cash Per Share₹233.88
Tangible Book Value Per Share₹1.12K
Margins
Gross margin is 65.38%, with operating margin of 17.83%, and net profit margin of 15.65%.
Gross Margin65.38%
Operating Margin17.83%
Pretax Margin19.51%
Net Profit Margin15.65%
EBITDA Margin23.20%
EBIT Margin20.61%
Analyst Forecast
The average price target for Alkem Laboratories Ltd. is ₹6,416.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹6,416.67
Price Target Upside15.45% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast13.48%
EPS Growth Forecast6.18%